Skip to main content
Matthew Weinstock, MD, Oncology, Boston, MA, Beth Israel Deaconess Medical Center

MatthewJonathanWeinstockMD

Oncology • Boston, MA

Hematologic Malignancy and Stem Cell Transplant, Attending Physician

Join to view full profile

Dr. Weinstock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weinstock's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Transcriptome Sequencing Demonstrates Unique Signature Associated with Durable Clinical Response to DC/AML Fusion Vaccine
    Matthew Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • T Cells Educated By DC/AML Fusions in the Context of 4-1BB Costimulation As a Potent Strategy for Adoptive Cellular Therapy
    Matthew Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma
    Matthew Weinstock, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Triplet Therapy Shows Promise in Phase 2 Study in Chronic Lymphocytic Leukemia
    Triplet Therapy Shows Promise in Phase 2 Study in Chronic Lymphocytic LeukemiaSeptember 15th, 2021
  • The Check up: Brandon Fryar of Presbyterian Health Plan
    The Check up: Brandon Fryar of Presbyterian Health PlanMay 17th, 2021
  • Webinar: Avoiding Interoperability Penalties
    Webinar: Avoiding Interoperability PenaltiesMarch 23rd, 2021
  • Join now to see all

Hospital Affiliations

Dr. Matthew Weinstock, Dr. Matthew Weinstock, MD, Dr. M Weinstock, Dr. Matthew Jonathan Weinstock